Vivimed Labs Admitted to Corporate Insolvency Resolution Process

Vivimed Labs Ltd has been admitted to the Corporate Insolvency Resolution Process (CIRP) by the Hon’ble National Company Law Tribunal (NCLT), Bengaluru Bench, through an order dated April 15, 2026. The petition was filed by M/s Blue Cube Germany Assets GMBH & Co.KG, an operational creditor, under Section 9 of the Insolvency and Bankruptcy Code, 2016. The operational debt amounts to ₹32,78,60,844/-, inclusive of interest, arising from the company's failure to repay dues for perchloroethylene supplied between December 2012 and January 2014 by Dow Europe GmbH, whose rights were later acquired by Blue Cube Germany Assets. An Interim Resolution Professional (IRP) has been appointed, and the case is listed for June 24, 2026, awaiting the IRP report.